col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


34 Results       Page 1

 [1] 
Elsevier: Biochimie
  original article Date Title Authors   All Authors
1 [GO] 2025―Aug―07 A clot to uncover: SARS-CoV-2 nucleocapsid can outcompete the FOXP3 forkhead domain for DNA binding in vitro Keiran McInnes, Sylvia Fanucchi
2 [GO] 2024―May―14 In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: implication for SARS-CoV-2 entry into host cells and susceptibility to COVID-19 Matteo Calcagnile, Fabrizio Damiano, Giambattista Lobreglio, Luisa Siculella, Maria Pia Bozzetti, Patricia Forgez, et al. (+5)
3 [GO] 2024―May―03 Myelin basic protein antagonizes the SARS-CoV-2 protein ORF3a-induced autophagy inhibition George A. Saratov, Alexey A. Belogurov, Anna A. Kudriaeva
4 [GO] 2024―Mar―01 Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y Bernardo R. Oliveira, Inga Nehlmeier, Amy Madeleine Kempf, Vaishnavi Venugopalan, Maren Rehders, Marianne E.P. Ceniza, et al. (+4)
5 [GO] 2023―May―23 Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent? Kasra Jahankhani, Fatemeh Ahangari, Ian M. Adcock, Esmail Mortaz
6 [GO] 2023―Mar―16 At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics Florian Poydenot, Alice Lebreton, Jacques Haiech, Bruno Andreotti
7 [GO] 2022―Oct―15 Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro Nataliya Miropolskaya, Maxim Kozlov, Ivan Petushkov, Maria Prostova, Danil Pupov, Daria Esyunina, et al. (+2)
8 [GO] 2022―Aug―09 Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19 Aurélien Philippe, Mathilde Puel, Céline Narjoz, Nicolas Gendron, Marie Agnès Durey-Dragon, Benoit Vedie, et al. (+8)
9 [GO] 2022―Jun―17 Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2 Vignesh Mariappan, Pajanivel Ranganadin, Lokesh Shanmugam, S.R. Rao, Agieshkumar Balakrishna Pillai
10 [GO] 2022―May―26 Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90 Kehinde S. Ayinde, Glaucia M.S. Pinheiro, Carlos H.I. Ramos
11 [GO] 2022―Jan―26 The enzymes in COVID-19: A review Maria Helena Menezes Estevam Alves, Layla Carvalho Mahnke, Tifany Cerqueira Macedo, Thais Ketinly dos Santos Silva, Luiz Bezerra de Carvalho Junior
12 [GO] 2021―Nov―15 SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale Alexander B. Sigalov
13 [GO] 2021―Oct―25 Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies Didac Martí, Marc Alsina, Carlos Alemán, Oscar Bertran, Pau Turon, Juan Torras
14 [GO] 2021―Sep―21 On the footsteps of Hippocrates, Sanctorius and Harvey to better understand the influence of cold on the occurrence of COVID-19 in European countries in 2020 Philippe Icard, Luca Simula, Joana Rei, Ludovic Fournel, Vincent DE. Pauw, Marco Alifano
15 [GO] 2021―Sep―08 Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines Walid Al-Zyoud, Hazem Haddad
16 [GO] 2021―Jun―18 Coronaviruses, cholesterol and statins: Involvement and application for Covid-19 Stéphane Orlowski, Jean-Jacques Mourad, Antonio Gallo, Eric Bruckert
17 [GO] 2021―Jun―16 What do secreted phospholipases A2 have to offer in combat against different viruses up to SARS-CoV-2? Jože Pungerčar, Franck Bihl, Gérard Lambeau, Igor Križaj
18 [GO] 2021―May―31 Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer Michael J. Story
19 [GO] 2021―May―11 Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein Shaojie Ma, Hui Li, Jun Yang, Kunqian Yu
20 [GO] 2021―Feb―25 SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators Mayssa Hachem
21 [GO] 2021―Jan―20 Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2 Mira A.M. Behnam
22 [GO] 2020―Nov―12 The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response Philippe Icard, Hubert Lincet, Zherui Wu, Antoine Coquerel, Patricia Forgez, Marco Alifano, Ludovic Fournel
23 [GO] 2020―Nov―09 Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein Matteo Calcagnile, Patricia Forgez, Antonio Iannelli, Cecilia Bucci, Marco Alifano, Pietro Alifano
24 [GO] 2020―Nov―06 Special Section Involvement of lipids in the occurrence of COVID-19 Vincent Rioux, Michel Record
25 [GO] 2020―Nov―05 Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses Céline Luquain-Costaz, Maxence Rabia, Françoise Hullin-Matsuda, Isabelle Delton
26 [GO] 2020―Oct―25 Membrane heist: Coronavirus host membrane remodeling during replication Jingshu Zhang, Yun Lan, Sumana Sanyal
27 [GO] 2020―Sep―22 The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, Uma Maheswari Krishnan
28 [GO] 2020―Sep―10 May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Pierre Weill, Claire Plissonneau, Philippe Legrand, Vincent Rioux, Ronan Thibault
29 [GO] 2020―Sep―03 Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Pierre-Jean Ferron, Thomas Gicquel, Bruno Mégarbane, Bruno Clément, Bernard Fromenty
30 [GO] 2020―Aug―14 Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? Razieh Dowran, Seyed Fazel Nabavi, Solomon Habtemariam, Maciej Banach, Shiva Shahmohamadnejad, Cosmin Andrei Cismaru, et al. (+3)
31 [GO] 2020―Jul―08 High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification Isabelle Dugail, Ez-Zoubir Amri, Nicolas Vitale
32 [GO] 2020―May―30 The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway Frédéric Carrière, Sonia Longhi, Michel Record
33 [GO] 2020―May―29 SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention Ismail Sami Mahmoud, Yazun Bashir Jarrar, Walhan Alshaer, Said Ismail
34 [GO] 2020―Apr―16 Renin-angiotensin system at the heart of COVID-19 pandemic Marco Alifano, Pietro Alifano, Patricia Forgez, Antonio Iannelli
 [1] 

34 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec